🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to compare the efficacy of UMEC/VI Inhalation Powd...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-15
Trial ID
NCT01899742
Treatments Being Tested
This is a descriptive observational open non-comparative study of the safet...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 1
Start Date
2004-03
Trial ID
NCT00620516
The purpose of this study is to evaluate the site and mechanisms responsibl...
Status
Recruiting
Location
Arthur F Gelb Medical Corporation
Start Date
2007-10
Trial ID
NCT01225913
The purpose of this study is to evaluate the effects on lung function of a ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02
Trial ID
NCT01751113
This is a randomised, double-blind, double-dummy, multinational, multicentr...
Status
Completed
Location
205.389.1020 Boehringer Ingelheim Investigational Site
Start Date
2008-01
Trial ID
NCT00563381
Treatments Being Tested
The aim of the study is to investigate whether the early introduction of ma...
Status
Completed
Location
205.479.01017 Boehringer Ingelheim Investigational Site
Start Date
2011-11
Trial ID
NCT01483625
Treatments Being Tested
Different medications are often used in combination for the condition COPD ...
Status
Completed
Location
Asthma and Allergy Research Group, Ninewells Hospital and Medical School
Start Date
2006-10
Trial ID
NCT00996697
Treatments Being Tested
This study was designed to evaluate the effects on lung function of a combi...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12
Trial ID
NCT00325169
Treatments Being Tested
This is a comparator study to assess the relative efficacy of the combinati...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-06
Trial ID
NCT00361959
Treatments Being Tested
The study is intended to characterize the lung function profile of BI1744 i...
Status
Completed
Location
1222.39.32003 Boehringer Ingelheim Investigational Site
Start Date
2010-01
Trial ID
NCT01040689